EQL Pharma AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2021-05-12 | EQL Pharma AB | Martin Kristofferson | Other member of the company's administrative, management or supervisory body | Acquisition | 2 500 | 37 | SEK | 92 500 | 2021-05-10 |
| 2021-05-12 | EQL Pharma AB | Martin Kristofferson | Other member of the company's administrative, management or supervisory body | Acquisition | 2 219 | 38 | SEK | 84 322 | 2021-05-11 |
| 2021-05-18 | EQL Pharma AB | Martin Kristofferson | Other member of the company's administrative, management or supervisory body | Acquisition | 2 781 | 37,5 | SEK | 104 287,5 | 2021-05-17 |
| 2021-08-17 | EQL Pharma AB | Martin Kristofferson | Other member of the company's administrative, management or supervisory body | Acquisition | 2 700 | 35,5 | SEK | 95 850 | 2021-08-16 |
| 2021-08-23 | EQL Pharma AB | Christer Fåhraeus | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 6 105 | 36,8 | SEK | 224 664 | 2021-08-22 |
| 2021-09-02 | EQL Pharma AB | Martin Kristofferson | Other member of the company's administrative, management or supervisory body | Subscription | 46 000 | 2,23 | SEK | 102 580 | 2021-08-31 |
| 2021-09-02 | EQL Pharma AB | Cornelia Lindström | Other member of the company's administrative, management or supervisory body | Subscription | 46 000 | 2,23 | SEK | 102 580 | 2021-08-31 |
| 2021-09-20 | EQL Pharma AB | Emanuel Gunnarsson Eriksson | Chief Financial Officer (CFO) | Exercise increase | 200 000 | 15 | SEK | 3 000 000 | 2021-09-16 |
| 2021-09-20 | EQL Pharma AB | Emanuel Gunnarsson Eriksson | Chief Financial Officer (CFO) | Exercise decrease | 200 000 | 15 | SEK | 3 000 000 | 2021-09-16 |
| 2021-09-20 | EQL Pharma AB | Emanuel Gunnarsson Eriksson | Chief Financial Officer (CFO) | Disposal | 8 000 | 37,52 | SEK | 300 160 | 2021-09-15 |
| 2021-09-20 | EQL Pharma AB | Christer Fåhraeus | Chief Executive Officer (CEO)/Managing Directory | Disposal | 200 000 | 15 | SEK | 3 000 000 | 2021-09-16 |
| 2021-12-14 | EQL Pharma AB | Axel Schörling | Deputy CEO/Deputy Managing Director | Subscription | 400 000 | 1,35 | SEK | 540 000 | 2021-12-09 |
| 2022-02-18 | EQL Pharma AB | Per Svangren | Member of the Board of Directors | Acquisition | 10 000 | 35,494 | SEK | 354 935 | 2022-02-16 |
| 2022-06-21 | EQL Pharma AB | Christer Fåhraeus | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 1 852 | 27 | SEK | 50 004 | 2022-06-19 |
| 2022-06-21 | EQL Pharma AB | Christer Fåhraeus | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 5 000 | 26,95 | SEK | 134 750 | 2022-06-16 |
| 2022-06-21 | EQL Pharma AB | Christer Fåhraeus | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 1 438 | 27 | SEK | 38 826 | 2022-06-16 |
| 2022-09-19 | EQL Pharma AB | Christer Fåhraeus | Chairman of the Board of Directors | Acquisition | 45 077 | 29,99 | SEK | 1 351 859,23 | 2022-09-15 |
| 2022-09-26 | EQL Pharma AB | Emanuel Gunnarsson Eriksson | Other member of the company's administrative, management or supervisory body | Disposal | 13 000 | 28,46 | SEK | 369 980 | 2022-09-21 |
| 2022-09-29 | EQL Pharma AB | Christer Fåhraeus | Chairman of the Board of Directors | Acquisition | 5 000 | 28,3 | SEK | 141 500 | 2022-09-28 |
| 2022-09-29 | EQL Pharma AB | Christer Fåhraeus | Chairman of the Board of Directors | Acquisition | 5 000 | 28,6 | SEK | 143 000 | 2022-09-27 |